Company
Investment-firm
Last deal
$250.M
Amount
Post-IPO Equity
Stage
10.02.2022
Date
10
all rounds
$553.1M
Total amount
General
About Company
Twist Bioscience is a synthetic biology company that develops a silicon-based manufacturing process for the production of synthetic DNA.
Industry
Sector :
Subsector :
Keywords :
Also Known As
Twist
founded date
01.01.2013
Number of employees
Company Type
For Profit
Last funding type
Post-IPO Equity
IPO status
Private
Contacts
location
Phone number
Website URL